Severe Acute Respiratory News and Research

RSS

How diet, supplements and lifestyle changes can help battle COVID

A recent editorial in the journal Nutrients emphasizes how efficacious non-pharmacological interventions in conjunction with the promotion of healthy lifestyle and dietary patterns may improve overall health status and reduce the risk of infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as the potential adverse effects of coronavirus disease 2019 (COVID-19).

6 Jan 2022

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

The LIVE-AIR phase 3 clinical trial is associated with early treatment of hyperinflammatory response with the humanized monoclonal antibody lenzilumab in COVID-19 patients with decreased oxygen saturation. The study results are posted to the medRxiv* preprint server.

6 Jan 2022

New method to estimate how individual mutations affect transmission of SARS-CoV-2

A new study, posted to the medRxiv* preprint server, constructs an analytical SIR-based epidemiological model to analyze the effects of mutations on SARS-CoV-2 transmission from genomic surveillance data.

5 Jan 2022

After SARS-CoV-2 booster dose memory B cells adapt to Omicron

Memory B cells never forget recurrent viral exposures and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is no exception, according to a new medRxiv* preprint study.

5 Jan 2022

Scientists estimate transmission advantage of Omicron over Delta variant as +105%

Researchers use statistical models to assess the transmission of the SARS-CoV-2 Omicron using variant-specific screening tests and genome sequencing.

5 Jan 2022

A new model for predicting COVID-19 severity at diagnosis

Researchers estimate the probabilities of hospitalization and mortality from COVID-19 according to individual risk factors and number of vaccine doses.

5 Jan 2022

Booster dose elicits cross-reactive humoral immunity against SARS-CoV-2 Delta and Omicron variants

Researchers determine the cross-reactivity of the SARS-CoV-2 spike glycoprotein-induced antibodies before and after a third SARS-CoV-2 vaccine dose.

5 Jan 2022

Monoclonal antibody treatment of COVID-19 reduces viral shedding

Researchers aim to understand the potential benefits of mAbs in preventing and treating SARS-CoV-2 infection.

5 Jan 2022

Impact of delaying the lifting of SARS-CoV-2 lockdown restrictions

New study findings provided critical insights into competitive behavior and the relative transmissibility of SARS-CoV-2 variants, which could be used for planning responses to future emerging variants and exploring co-infections with different strains of SARS-CoV-2 and influenza virus.

5 Jan 2022

Integrin/TGF-β1 inhibitors highly effective in attenuating COVID-19 severity

New study results suggest that integrin inhibitors have the potential to both prevent infection with SARS-CoV-2, including the Delta and Omicron variants, and to decrease TGF-β levels, resulting in a decrease in COVID-19 severity, hospitalization, and death, especially in vulnerable and unvaccinated populations.

5 Jan 2022

Exploring SARS-CoV-2-like viruses to mitigate the risk of zoonotic transmission to humans

In a new study, a team of researchers developed a genetic assay to evaluate several clade 2 and clade 3 receptor-binding domains (RBD) of spike (S) protein sequences of genus sarbecovirus.

5 Jan 2022

Study findings suggest spread of Omicron can be ascribed to immune evasiveness rather than an increase in transmissibility

Researchers investigate the household transmission of the Omicron VOC and increased immune evasiveness of both the Omicron and Delta variants

5 Jan 2022

Severe Acute Respiratory News and Research

How diet, supplements and lifestyle changes can help battle COVID

LIVE-AIR trial demonstrates efficacy of Lenzilumab for treatment of COVID patients with decreased oxygen saturation

New method to estimate how individual mutations affect transmission of SARS-CoV-2

After SARS-CoV-2 booster dose memory B cells adapt to Omicron

Scientists estimate transmission advantage of Omicron over Delta variant as +105%

A new model for predicting COVID-19 severity at diagnosis

Booster dose elicits cross-reactive humoral immunity against SARS-CoV-2 Delta and Omicron variants

Monoclonal antibody treatment of COVID-19 reduces viral shedding

Impact of delaying the lifting of SARS-CoV-2 lockdown restrictions

Integrin/TGF-β1 inhibitors highly effective in attenuating COVID-19 severity

Exploring SARS-CoV-2-like viruses to mitigate the risk of zoonotic transmission to humans

Study findings suggest spread of Omicron can be ascribed to immune evasiveness rather than an increase in transmissibility

Hospitalization and death associated with SARS-CoV-2 Omicron variant compared to Delta variant

Exploring vaccine-induced cellular immunity against SARS-CoV-2 Omicron variant

Comparison of the mutational profile of Omicron with other SARS-CoV-2 lineages

Statistical analysis reveals less severe COVID-19 outcome due to Omicron variant

Efficacy of rapid antigen diagnostic tests for the detection of infectious individuals at mass gatherings

COVID-19 mRNA vaccines offer protection against Omicron variant in pregnancy

Efficacy of COVID-19 convalescent plasma therapy in patients with hematological malignancies and COVID-19

Oral bacteria-based SARS-CoV-2 vaccine platform

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News